?
Catelani Michael
President, COO & CFO
Anixa Biosciences, Inc.
US, San Jose [HQ]
CIK
1689394
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
18,135
Price per Share :
$2.28
Equivalence :
$41,347.80
Transaction History
-
P18,135 Shares After TransactionValue : $48,239.10$14,630.00Transaction Date : 04/21/22
-
Footnotes
-
-
Footnotes:No footnote found.
-
A27,772 Shares After TransactionValue : $74,706.68$3,004.73Transaction Date : 10/31/23
-
Footnotes
-
-
Footnotes:#1 The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares.#2 In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on October 31, 2023.
-
A21,155 Shares After TransactionValue : $73,407.85$3,001.55Transaction Date : 04/28/23
-
Footnotes
-
-
Footnotes:#1 The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares.#2 In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on April 28, 2023.
-
P12,635 Shares After TransactionValue : $31,966.55$6,347.77Transaction Date : 04/20/22
-
Footnotes
-
-
Footnotes:No footnote found.
-
A28,961 Shares After TransactionValue : $72,981.72$2,996.28Transaction Date : 04/30/24
-
Footnotes
-
-
Footnotes:#1 The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares.#2 In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on April 30, 2024.